314 related articles for article (PubMed ID: 16806603)
1. The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence.
Daza P; Banda R; Misoya K; Katsulukuta A; Gessner BD; Katsande R; Mhlanga BR; Mueller JE; Nelson CB; Phiri A; Molyneux EM; Molyneux ME
Vaccine; 2006 Sep; 24(37-39):6232-9. PubMed ID: 16806603
[TBL] [Abstract][Full Text] [Related]
2. The Elimination of Haemophilus influenzae type b meningitis following conjugate vaccine introduction in Senegal.
Cissé MF; Breugelmans JG; Bâ M; Diop MB; Faye PC; Mhlanga B; Mueller JE; Koffi D; Gessner BD
Pediatr Infect Dis J; 2010 Jun; 29(6):499-503. PubMed ID: 20042917
[TBL] [Abstract][Full Text] [Related]
3. Haemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil.
Ribeiro GS; Lima JB; Reis JN; Gouveia EL; Cordeiro SM; Lobo TS; Pinheiro RM; Ribeiro CT; Neves AB; Salgado K; Silva HR; Reis MG; Ko AI
Vaccine; 2007 May; 25(22):4420-8. PubMed ID: 17449150
[TBL] [Abstract][Full Text] [Related]
4. Introduction of Haemophilus influenzae type B conjugate vaccine into routine immunization in Ghana and its impact on bacterial meningitis in children younger than five years.
Renner LA; Newman MJ; Ahadzie L; Antwi-Agyei KO; Eshetu M
Pediatr Infect Dis J; 2007 Apr; 26(4):356-8. PubMed ID: 17414404
[TBL] [Abstract][Full Text] [Related]
5. Haemophilus influenzae type b conjugate vaccine is highly effective in the Ugandan routine immunization program: a case-control study.
Lee EH; Lewis RF; Makumbi I; Kekitiinwa A; Ediamu TD; Bazibu M; Braka F; Flannery B; Zuber PL; Feikin DR
Trop Med Int Health; 2008 Apr; 13(4):495-502. PubMed ID: 18312475
[TBL] [Abstract][Full Text] [Related]
6. Incidence of Haemophilus influenzae type b and other invasive diseases in South Korean children.
Kim JS; Jang YT; Kim JD; Park TH; Park JM; Kilgore PE; Kennedy WA; Park E; Nyambat B; Kim DR; Hwang PH; Kim SJ; Eun SH; Lee HS; Cho JH; Kim YS; Chang SJ; Huang HF; Clemens JD; Ward JI
Vaccine; 2004 Sep; 22(29-30):3952-62. PubMed ID: 15364444
[TBL] [Abstract][Full Text] [Related]
7. Impact of vaccination against Haemophilus influenzae type b with and without a booster dose on meningitis in four South American countries.
Garcia S; Lagos R; Muñoz A; Picón T; Rosa R; Alfonso A; Abriata G; Gentile A; Romanin V; Regueira M; Chiavetta L; Agudelo CI; Castañeda E; De la Hoz F; Higuera AB; Arce P; Cohen AL; Verani J; Zuber P; Gabastou JM; Pastor D; Flannery B; Andrus J
Vaccine; 2012 Jan; 30(2):486-92. PubMed ID: 22085550
[TBL] [Abstract][Full Text] [Related]
8. Acute bacterial meningitis among children < 5 years of age in Oman: a retrospective study during 2000-2005.
Dash N; Panigrahi D; Al Khusaiby S; Al Awaidy S; Bawikar S
J Infect Dev Ctries; 2008 Apr; 2(2):112-5. PubMed ID: 19738334
[TBL] [Abstract][Full Text] [Related]
9. Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia.
Gessner BD; Sedyaningsih ER; Griffiths UK; Sutanto A; Linehan M; Mercer D; Mulholland EK; Walker DG; Steinhoff M; Nadjib M
Pediatr Infect Dis J; 2008 May; 27(5):438-43. PubMed ID: 18398383
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of haemophilus influenzae type B conjugate vaccine for prevention of meningitis in Senegal.
Fleming JA; Dieye Y; Ba O; Mutombo wa Mutombo B; Diallo N; Faye PC; Ba M; Cisse MF; Diallo AG; Ba M; Slack MP; Weiss NS
Pediatr Infect Dis J; 2011 May; 30(5):430-2. PubMed ID: 21099444
[TBL] [Abstract][Full Text] [Related]
11. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
[TBL] [Abstract][Full Text] [Related]
12. Haemophilus influenzae type b conjugate vaccine impact against purulent meningitis in Rwanda.
Muganga N; Uwimana J; Fidele N; Gahimbare L; Gessner BD; Mueller JE; Mhlanga BR; Katsande R; Herbinger KH; Rugambwa C
Vaccine; 2007 Sep; 25(39-40):7001-5. PubMed ID: 17709159
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.
Nolan T; Bernstein H; Blatter MM; Bromberg K; Guerra F; Kennedy W; Pichichero M; Senders SD; Trofa A; Collard A; Sullivan DC; Descamps D
Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952
[TBL] [Abstract][Full Text] [Related]
14. Impact of Haemophilus influenzae type b (Hib) conjugate vaccines on Haemophilus influenzae meningitis in Wisconsin.
Enders PJ; Trepka MJ; Davis JP
WMJ; 2000 Aug; 99(5):45-8. PubMed ID: 11043070
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.
Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L;
Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171
[TBL] [Abstract][Full Text] [Related]
16. Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation.
Platonov AE; Griffiths UK; Voeykova MV; Platonova OV; Shakhanina IL; Chistyakova GG; Robertson SE;
Vaccine; 2006 Mar; 24(13):2367-76. PubMed ID: 16413949
[TBL] [Abstract][Full Text] [Related]
17. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
[TBL] [Abstract][Full Text] [Related]
18. Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil.
Ribeiro GS; Reis JN; Cordeiro SM; Lima JB; Gouveia EL; Petersen M; Salgado K; Silva HR; Zanella RC; Almeida SC; Brandileone MC; Reis MG; Ko AI
J Infect Dis; 2003 Jan; 187(1):109-16. PubMed ID: 12508153
[TBL] [Abstract][Full Text] [Related]
19. Haemophilus influenzae type b disease among children in rural Mozambique: impact of vaccine introduction.
Sigaúque B; Vubil D; Sozinho A; Quintó L; Morais L; Sacoor C; Carvalho MG; Verani JR; Alonso PL; Roca A
J Pediatr; 2013 Jul; 163(1 Suppl):S19-24. PubMed ID: 23773589
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of Haemophilus influenzae type B conjugate vaccine on prevention of pneumonia and meningitis in Bangladeshi children: a case-control study.
Baqui AH; El Arifeen S; Saha SK; Persson L; Zaman K; Gessner BD; Moulton LH; Black RE; Santosham M
Pediatr Infect Dis J; 2007 Jul; 26(7):565-71. PubMed ID: 17596795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
